Clinical Trial Update: Evolut Low Risk TAVR Trial

By Adam Pick on April 25, 2019

If you are interested in the new clinical trial results for low-risk TAVR devices, I just posted a follow-up story to my last article about the PARTNER 3 research study by Edwards Lifesciences.

This new post features data and analysis for the the Evolut Low Risk Trial by Medtronic.

 

 

To see the story, click here.

Keep on tickin!
Adam


Written by Adam Pick
- Patient & Website Founder

Adam Pick is a heart valve patient and author of The Patient's Guide To Heart Valve Surgery. In 2006, Adam founded HeartValveSurgery.com to educate and empower patients. This award-winning website has helped over 10 million people fight heart valve disease. Adam has been featured by the American Heart Association and Medical News Today.

Adam Pick is a heart valve patient and author of The Patient's Guide To Heart Valve Surgery. In 2006, Adam founded HeartValveSurgery.com to educate and empower patients. This award-winning website has helped over 10 million people fight heart valve disease. Adam has been featured by the American Heart Association and Medical News Today.

Leave a Reply

Adam's Newest Blogs

Adam's Newest Posts

Tom Felt Like a “Walking Time Bomb” After Aortic Aneurysm Diagnosis Learn More.

11 Weeks After TAVR, Mick Jagger Wows 60,000 Fans in Chicago!!! Learn More.

Newest Community Post

Rob says, "Had a pretty rough week dealing with the"
Read more

Kaaren says, "All done! New tissue valve a week ago"
Read more

Monica says, "I returned to Cleveland Clinic today for"
Read more

Find Heart Valve Surgeons

Search 1,500 patient-recommended surgeons